ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IBIO iBio Inc

4.01
0.65 (19.35%)
Mar 28 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
iBio Inc IBIO AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.65 19.35% 4.01 20:00:00
Open Price Low Price High Price Close Price Prev Close
4.20 3.66 4.98 4.06 3.36
more quote information »

Recent News

Date Time Source Heading
3/27/202407:00GLOBEiBio and AstralBio Announce Transformative AI drug discovery..
3/26/202419:35GLOBEiBio Announces $15.0 Million Private Placement
2/26/202407:59EDGAR2Form 8-K - Current report
2/26/202407:45GLOBEiBio Announces Sale of Preclinical PD-1 Agonist Antibody..
2/21/202416:55EDGAR2Form 8-K - Current report
1/19/202416:36EDGAR2Form 8-K - Current report
1/16/202408:15GLOBEiBio Announces Participation in 23rd Annual PepTalk..
1/10/202413:24EDGAR2Form S-8 - Securities to be offered to employees in employee..
1/08/202416:30EDGAR2Form 8-K - Current report
1/04/202408:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/26/202307:44EDGAR2Form 8-K - Current report
12/26/202307:15GLOBEiBio Amends and Extends Maturity of Credit Agreement
12/08/202316:17EDGAR2Form 8-K - Current report
12/06/202309:13EDGAR2Form 8-K - Current report
12/06/202308:59EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/05/202308:00GLOBEiBio, Inc. Announces Pricing of $4.5 Million Public Offering
12/05/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
11/30/202308:55EDGAR2Form S-1/A - General form for registration of securities..
11/28/202308:36EDGAR2Form 8-K - Current report
11/27/202317:20GLOBEiBio Announces Reverse Stock Split
11/03/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202308:24GLOBEiBio Further Expands Tech Stack with ShieldTx™; Enhances..
10/27/202316:29EDGAR2Form S-1 - General form for registration of securities under..
10/26/202308:20EDGAR2Form DEF 14A - Other definitive proxy statements
10/16/202316:59EDGAR2Form PRE 14A - Other preliminary proxy statements
10/10/202308:56EDGAR2Form 8-K - Current report
10/10/202308:00GLOBEiBio to Highlight Technology for Advancing Discovery of..
10/05/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/03/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202316:34EDGAR2Form 8-K - Current report
10/02/202306:45GLOBEiBio Explains Recent Filing of Registration Statement
9/29/202317:28EDGAR2Form POS AM - Post-Effective amendments for registration..
9/27/202316:31EDGAR2Form 8-K - Current report
9/27/202316:19GLOBEiBio Announces Filing of 2023 Annual Report on SEC Form 10-K
9/27/202316:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
9/21/202316:05GLOBEiBio Announces Amendment to Credit Agreement with Woodforest
9/21/202308:00EDGAR2Form 8-K - Current report
8/30/202316:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/24/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/24/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/14/202316:15GLOBEiBio Reports Triple Milestone: In Vivo Proof-of-Concept for..
8/14/202315:21EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/07/202316:01EDGAR2Form 8-K - Current report
8/07/202309:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
8/04/202316:47EDGAR2Form 8-K - Current report
7/28/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/13/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/10/202308:29EDGAR2Form 8-K - Current report
6/27/202308:00GLOBEiBio Appoints Dr. Martin Brenner as CEO, Felipe Duran as CFO..
6/12/202316:15GLOBEiBio Forges Research Collaboration with the National..

Your Recent History

Delayed Upgrade Clock